Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Comparison of first-line chemotherapy regimens for ovarian carcinosarcoma: a single institution case series and review of the literature

Fig. 1

Progression-Free Survival and Overall Survival for Ifosfamide/Paclitaxel vs Carboplatin/Paclitaxel. a Kaplan Meier curve comparing PFS by initial chemotherapy: Ifosfamide/Paclitaxel compared to Carboplatin/Paclitaxel. Analyzed by log-rank Mantel-Cox test. p = 0.025. b Kaplan Meier curve comparing OS by initial chemotherapy: Ifosfamide/Paclitaxel compared to Carboplatin/Paclitaxel. Analyzed by log-rank Mantel-Cox test. p = 0.350

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us